AMLX R&D to Revenue
Amylyx Pharmaceuticals Inc · R&D to Revenue
AMLX R&D to Revenue
Latest reported0.00%period ending
AMLX Quarterly R&D/Revenue (0.00% → 0.00%)
Latest values, visible window
High-resolution chart · PNG
AMLX r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -3,442.406% | |
| 5,105.0481% | |
| -2,261.8768% | |
| 41.2982% | |
| 41.4149% | |
| 29.2493% | |
| 29.5716% | |
| 33.8691% | |
| 104.2403% | |
| 7,221.4493% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |